Martin Larbig

416 total citations
13 papers, 287 citations indexed

About

Martin Larbig is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Martin Larbig has authored 13 papers receiving a total of 287 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Martin Larbig's work include Diabetes Management and Research (11 papers), Diabetes Treatment and Management (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Martin Larbig is often cited by papers focused on Diabetes Management and Research (11 papers), Diabetes Treatment and Management (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). Martin Larbig collaborates with scholars based in Germany, United Kingdom and South Korea. Martin Larbig's co-authors include Thomas Först, Andreas Pfützner, Andreas Fritsche, Hans‐Ulrich Häring, A Pfützner, David R. Owens, Thomas Schrepfer, Matthias M. Weber, Andreas Caduff and S Först and has published in prestigious journals such as Diabetes Care, Diabetes Obesity and Metabolism and Diabetes Technology & Therapeutics.

In The Last Decade

Martin Larbig

13 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Larbig Germany 9 216 89 75 40 32 13 287
John Paul Lock United States 8 132 0.6× 45 0.5× 55 0.7× 29 0.7× 16 0.5× 15 197
Sarah Borgman United States 4 226 1.0× 108 1.2× 30 0.4× 95 2.4× 13 0.4× 4 253
Andrew K. Balo United States 8 295 1.4× 176 2.0× 19 0.3× 166 4.2× 37 1.2× 12 359
Erwin S. Budiman United States 7 289 1.3× 175 2.0× 25 0.3× 152 3.8× 51 1.6× 8 363
Jill M. Abelseth United States 6 459 2.1× 272 3.1× 51 0.7× 199 5.0× 27 0.8× 7 490
Lars Krinelke Germany 7 364 1.7× 205 2.3× 26 0.3× 166 4.2× 44 1.4× 8 428
Christie Beatson United States 9 392 1.8× 249 2.8× 20 0.3× 178 4.5× 22 0.7× 10 443
I. M. E. Wentholt Netherlands 11 561 2.6× 327 3.7× 52 0.7× 268 6.7× 105 3.3× 18 702
S. Baillot-Rudoni France 11 226 1.0× 161 1.8× 49 0.7× 53 1.3× 7 0.2× 22 327
Pauline Genter United States 9 92 0.4× 28 0.3× 31 0.4× 20 0.5× 5 0.2× 13 225

Countries citing papers authored by Martin Larbig

Since Specialization
Citations

This map shows the geographic impact of Martin Larbig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Larbig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Larbig more than expected).

Fields of papers citing papers by Martin Larbig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Larbig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Larbig. The network helps show where Martin Larbig may publish in the future.

Co-authorship network of co-authors of Martin Larbig

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Larbig. A scholar is included among the top collaborators of Martin Larbig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Larbig. Martin Larbig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Heise, Tim, Martin Larbig, S. Patel, et al.. (2014). The dipeptidyl peptidase‐4 inhibitor linagliptin lowers postprandial glucose and improves measures of β ‐cell function in type 2 diabetes. Diabetes Obesity and Metabolism. 16(10). 1036–1039. 11 indexed citations
2.
Pscherer, Stefan, et al.. (2012). In Type 2 Diabetes Patients, Insulin Glargine is Associated with Lower Postprandial Release of Intact Proinsulin Compared with Sulfonylurea Treatment. Journal of Diabetes Science and Technology. 6(3). 634–640. 10 indexed citations
3.
Först, Thomas, et al.. (2010). Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β ‐cell protection in individuals with type 2 diabetes. Diabetes Obesity and Metabolism. 12(5). 437–441. 15 indexed citations
4.
Fritsche, Andreas, et al.. (2009). Comparison between a basal‐bolus and a premixed insulin regimen in individuals with type 2 diabetes–results of the GINGER study. Diabetes Obesity and Metabolism. 12(2). 115–123. 86 indexed citations
5.
Först, Thomas, Martin Larbig, Michael Safinowski, et al.. (2008). Effect of Insulin Glulisine on Microvascular Blood Flow and Endothelial Function in the Postprandial State. Diabetes Care. 31(5). 1021–1025. 12 indexed citations
6.
Först, S, et al.. (2006). Evaluation of CGMS ® During Rapid Blood Glucose Changes in Patients with Type 1 Diabetes. Diabetes Technology & Therapeutics. 8(2). 146–155. 20 indexed citations
7.
Larbig, Martin, et al.. (2005). Evaluation of the insulin application system Autopen 24®. Practical Diabetes International. 22(9). 364–366a. 2 indexed citations
8.
Nguyen, Mai P., et al.. (2004). Evaluation of SET–A New Device for the Measurement of Pain Perception in Comparison to Standard Measures of Diabetic Neuropathy. Diabetes Technology & Therapeutics. 6(5). 601–606. 2 indexed citations
9.
Pfützner, Andreas, A Pfützner, Martin Larbig, & Thomas Först. (2004). Role of Intact Proinsulin in Diagnosis and Treatment of Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. 6(3). 405–412. 43 indexed citations
10.
Pfützner, Andreas, Andreas Caduff, Martin Larbig, Thomas Schrepfer, & Thomas Först. (2004). Impact of Posture and Fixation Technique on Impedance Spectroscopy Used for Continuous and Noninvasive Glucose Monitoring. Diabetes Technology & Therapeutics. 6(4). 435–441. 47 indexed citations
11.
Pfützner, Andreas, Peter Herbert Kann, A Pfützner, et al.. (2004). Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.. PubMed. 50(9-10). 567–73. 30 indexed citations
12.
Larbig, Martin, et al.. (2003). Investigation on the accuracy of the blood glucose monitoring device Prestige IQ.. PubMed. 16(4). 257–61. 7 indexed citations
13.
Pfützner, Andreas, Norbert Hermanns, Stefan Schröder, et al.. (2002). Cross-sectional investigation on the accuracy of alternate site glucose testing using the Soft-Sense® glucose meter. Swiss Medical Weekly. 132(2526). 351–357. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John Paul Lock Breakdown of academic impact, for papers by Sarah Borgman Breakdown of academic impact, for papers by Andrew K. Balo Breakdown of academic impact, for papers by Erwin S. Budiman Breakdown of academic impact, for papers by Jill M. Abelseth Breakdown of academic impact, for papers by Lars Krinelke Breakdown of academic impact, for papers by Christie Beatson Breakdown of academic impact, for papers by I. M. E. Wentholt Breakdown of academic impact, for papers by S. Baillot-Rudoni Breakdown of academic impact, for papers by Pauline Genter
Rankless by CCL
2026